Education
About Us
Working with TipRanks
Follow Us
Arterra Bioscience SpA (IT:ARBS)
:ARBS
Total Valuation
Arterra Bioscience SpA has a market cap or net worth of €20.77M. The enterprise value is ―.
Market Cap€20.77M
Enterprise Value―
Share Statistics
Arterra Bioscience SpA has 6,658,493 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,658,493
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Arterra Bioscience SpA’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.10%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)9.10%
Return on Capital Employed (ROCE)0.12
Revenue Per Employee139.10K
Profits Per Employee44.56K
Employee Count30
Asset Turnover0.31
Inventory Turnover0.39
Valuation Ratios
The current PE Ratio of Arterra Bioscience SpA is 10.9. Arterra Bioscience SpA’s PEG ratio is 0.39.
PE Ratio10.9
PS Ratio3.13
PB Ratio1.14
Price to Fair Value1.14
Price to FCF32.67
Price to Operating Cash Flow18.65
PEG Ratio0.39
Income Statement
In the last 12 months, Arterra Bioscience SpA had revenue of 4.17M and earned 1.34M in profits. Earnings per share was 0.20.
Revenue4.17M
Gross Profit3.65M
Operating Income1.47M
Pretax Income1.70M
Net Income1.34M
EBITDA2.04M
Earnings Per Share (EPS)0.20
Cash Flow
In the last 12 months, operating cash flow was 1.90M and capital expenditures -858.60K, giving a free cash flow of 1.04M billion.
Operating Cash Flow1.90M
Free Cash Flow1.04M
Free Cash Flow per Share0.16
Dividends & Yields
Arterra Bioscience SpA pays an annual dividend of €0.13, resulting in a dividend yield of 4.33%
Dividend Per Share€0.13
Dividend Yield4.33%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.31
52-Week Price Change66.84%
50-Day Moving Average3.03
200-Day Moving Average2.62
Relative Strength Index (RSI)58.58
Average Volume (3m)55.55K
Important Dates
Arterra Bioscience SpA upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Arterra Bioscience SpA as a current ratio of 9.99, with Debt / Equity ratio of 3.12%
Current Ratio9.99
Quick Ratio8.37
Debt to Market Cap0.03
Net Debt to EBITDA-1.46
Interest Coverage Ratio1.08K
Taxes
In the past 12 months, Arterra Bioscience SpA has paid 364.78K in taxes.
Income Tax364.78K
Effective Tax Rate0.21
Enterprise Valuation
Arterra Bioscience SpA EV to EBITDA ratio is 4.93, with an EV/FCF ratio of 25.20.
EV to Sales2.41
EV to EBITDA4.93
EV to Free Cash Flow25.20
EV to Operating Cash Flow9.46
Balance Sheet
Arterra Bioscience SpA has €3.44M in cash and marketable securities with €308.44K in debt, giving a net cash position of €3.13M billion.
Cash & Marketable Securities€3.44M
Total Debt€308.44K
Net Cash€3.13M
Net Cash Per Share€0.47
Tangible Book Value Per Share€1.71
Margins
Gross margin is 40.13%, with operating margin of 35.19%, and net profit margin of 32.03%.
Gross Margin40.13%
Operating Margin35.19%
Pretax Margin40.77%
Net Profit Margin32.03%
EBITDA Margin48.94%
EBIT Margin40.81%
Analyst Forecast
The average price target for Arterra Bioscience SpA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―